- Home
- /
- Treatment
- /
- Page 91
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
N-tert-butyl-3-[5-methyl-2-{[4-(2-pryyolidin-1-ylethoxy)phenyl]amino}pyrimidin-4-yl-amino] benzenesulfonamide dihydrochloride monohydrate | Myelofibrosis | Impact Biomedicines;12526 High Bluff Drive, Suite 260;San Diego, California, 92130 | May 18, 2009 | |
Elosulfase alfa | Mucopolysaccharidosis Type IVA | BioMarin Pharmaceutical Inc.;105 Digital Drive;Novato, California, 94949 | May 15, 2009 | |
Aztreonam | Bronchiectasis | Gilead Sciences, Inc.;2025 1st Avenue;Seattle, Washington, 98121 | May 15, 2009 | |
Dimebon | Huntington disease | Medivation, Inc.;201 Spear Street;San Francisco, California, 94105 | May 12, 2009 | |
S-nitrosoglutathione | Cystic fibrosis | N30 PHARMAceuticals, LLC;3122 Sterling Circle;Boulder, Colorado, 80301 | May 12, 2009 | |
Recombinant adeno-associated virus (serotype 2) (rAAV2) gene transfer agent expressing RPE65 | Leber congenital amaurosis | AmpliPhi Biosciences Corporation;601 Union St., Suite 4200;Seattle, Washington, 98111 | May 11, 2009 | |
Ascorbic acid | Charcot-Marie-Tooth disease | Murigenetics SAS;Faculte de Medecine Timone, 13005 Marseille; | May 11, 2009 | |
Uridine triacetate | An antidote in the treatment of 5-fluorouracil or capecitabine poisoning | Wellstat Therapeutics Corp.;14200 Shady Grove Road, Suite 600;Rockville, Maryland, 20850 | May 1, 2009 | |
Antihemophilic factor (recombinant) formulated with sucrose reconstituted with liposome diluent | Hemophilia A | Bayer HealthCare LLC;555 Whiteplains Road;Tarrytown, New York, 10591 | April 29, 2009 | |
Eculizumab | Atypical hemolytic uremic syndrome | Alexion Pharmaceuticals, Inc.;352 Knotter Drive;Cheshire, Connecticut, 06410 | April 29, 2009 | |
Antisense oligonucleotide directed against connexin43 | Persistent corneal epithelial defects | CoDa Therapeutics, Inc.;10505 Sorrento Valley Road;San Diego, California, 92121 | April 27, 2009 | |
4,6,8-trihydroxy-10-(3,7,11-trimethyldodeca-2,6,10-trienyl)-5,10-dihydrodibenzo b,e][1,4]diazepin-11-one | Glioma | Thallion Pharmaceuticals, Inc.;7150 Alexander-Fleming; | April 27, 2009 | |
D-mannitol and L-proline | Cockayne syndrome | DNage B.V.;Darwinweg 24; | April 20, 2009 | |
Caplacizumab | Thrombotic thrombocytopenic purpura | Ablynx NV;Technologiepark 21, B-9052;Zwijnaarde | April 14, 2009 | |
ALX-0081 nanobody, directed towards the human A1 domain of von Willebrand factor | Thrombotic thrombocytopenic purpura | Ablynx NV;Technologiepark 21, B-9052;Zwijnaarde | April 14, 2009 | |
Chimeric murine/human IgG1 monoclonal antibody to human interleukin-3 receptor alpha chain | Acute myeloid leukemia | CSl Limited;45 Poplar Road; | April 3, 2009 | |
Allogeneic human aortic endothelial cells cultured in a porcine gelatin matrix | Prevention of arteriovenous fistula or arteriovenous graft failure in patients with end satge renal disease receiving hemodialysis or preparing for hemodialysis | Shire;300 Shire Way;Lexington, Massachusetts, 02421 | April 3, 2009 | |
Anti-T cell receptor murine monoclonal antibody | Prophylaxis of acute rejection of solid organ transplantation | Tolera Therapeutics, Inc.;4717 Campus Drive #800;Kalamazoo, Michigan, 49008 | April 3, 2009 | |
Vonapanitase | Focal segmental glomerulosclerosis | Proteon Therapeutics, Inc.;200 West Street;Waltham, Massachusetts, 02451 | April 3, 2009 | |
D-Phe-Cys-Tyr-D-Trp-Lys-Cys-Thr-Nh2 (disulfide bridge: 2-6) acetate | Melanoma, stages IIb through IV | Thallion Pharmaceuticals, Inc.;7150 Alexander-Fleming; | March 19, 2009 | |
2-(2-phenylvinyl)-4-[4-methylpiperazin-l-yl)]-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidine L(+) tartrate salt | Ovarian cancer | EntreMed, Inc.;Research Triangle Park Center, Suite 400;Durham, North Carolina, 27703 | March 18, 2009 | |
N-(5-tert-Butylisoxazol-3-yl)-N’-{4-[7-(2-(morpholin-4-yl)ethoxy) imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea di-hydrochloride salt | Acute myeloid leukemia | Daiichi Sankyo, Inc.;211 Mount Airy Road;Basking Ridge, New Jersey, 07920 | March 18, 2009 | |
Technetium Tc99m sulfur colloid injection, lyophilized | For localization of sentinel lymph nodes in patients with melanoma | Pharmalucence, Inc.;10 DeAngelo Drive;Bedford, Massachusetts, 01730 | March 17, 2009 | |
Beclomethasone | Ulcerative colitis | Aptalis Pharma US, Inc.;100 Somerset corporate Blvd;Bridgewater, New Jersey, 08807 | March 4, 2009 | |
Enzastaurin | Diffuse Large B-cell Lymphoma | Denovo Biopharma LLC;6331 Nancy Ridge Drive;San Diego, California, 92121 | March 4, 2009 |